Seike Y - Search Results

1

Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.

Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Ishida M, Seike Y, Terakawa H, Watanabe Y, Uehara T, Nishimura T. Oku N, et al. Among authors: seike y. J Nucl Med. 1997 Jul;38(7):1109-11. J Nucl Med. 1997. PMID: 9225799 Free article.

2

Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease.

Hashikawa K, Matsumoto M, Moriwaki H, Oku N, Okazaki Y, Seike Y, Uehara T, Tanabe H, Ohie Y, Kamada T, et al. Hashikawa K, et al. Among authors: seike y. J Nucl Med. 1995 Apr;36(4):690-6. J Nucl Med. 1995. PMID: 7699466 Free article.

3

Carbon dioxide reactivity by consecutive technetium-99m-HMPAO SPECT in patients with a chronically obstructed major cerebral artery.

Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Okazaki Y, Seike Y, Handa N, Uehara T, Kamada T, Nishimura T. Oku N, et al. Among authors: seike y. J Nucl Med. 1994 Jan;35(1):32-40. J Nucl Med. 1994. PMID: 8271057 Free article.

4

Super-early iodine-123-iodoamphetamine SPECT imaging of human primary motor cortex.

Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Seike Y, Ishida M, Handa N, Kamada T, Nishimura T. Oku N, et al. Among authors: seike y. J Nucl Med. 1995 Dec;36(12):2180-5. J Nucl Med. 1995. PMID: 8523101 Free article.

5

Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.

Fukuchi K, Hashikawa K, Seike Y, Moriwaki H, Oku N, Ishida M, Fujita M, Uehara T, Tanabe H, Kusuoka H, Nishimura T. Fukuchi K, et al. Among authors: seike y. J Nucl Med. 1997 Mar;38(3):467-70. J Nucl Med. 1997. PMID: 9074540 Free article.

6

Hemodynamic aspect of cerebral watershed infarction: assessment of perfusion reserve using iodine-123-iodoamphetamine SPECT.

Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Watanabe Y, Hougaku H, Handa N, Nishimura T. Moriwaki H, et al. Among authors: seike y. J Nucl Med. 1997 Oct;38(10):1556-62. J Nucl Med. 1997. PMID: 9379192 Free article.

7

SPECT findings in mitochondrial encephalomyopathy.

Watanabe Y, Hashikawa K, Moriwaki H, Oku N, Seike Y, Kodaka R, Ono J, Uehara T, Kusuoka H, Nishimura T. Watanabe Y, et al. Among authors: seike y. J Nucl Med. 1998 Jun;39(6):961-4. J Nucl Med. 1998. PMID: 9627326 Free article.

8

Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.

Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Fukuchi K, Hori M, Nishimura T. Moriwaki H, et al. Among authors: seike y. J Nucl Med. 1998 Aug;39(8):1348-53. J Nucl Med. 1998. PMID: 9708504 Free article.

9

Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: factors influencing the quantitative results.

Seike Y, Hashikawa K, Oku N, Moriwaki H, Yamamoto H, Fukuchi K, Watanabe Y, Matsumoto M, Hori M, Nishimura T. Seike Y, et al. Ann Nucl Med. 2004 Oct;18(7):563-72. doi: 10.1007/BF02984577. Ann Nucl Med. 2004. PMID: 15586629 Clinical Trial.

10

[Evaluation of 123I-iomazenil SPECT in patients with ischemic cerebrovascular disease: comparative study with 123I-IMP SPECT].

Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, Fujita M, Fukuchi K, Watanabe Y, Terakawa H, Uehara T, Nishimura T. Moriwaki H, et al. Among authors: seike y. Kaku Igaku. 1996 Jun;33(6):587-97. Kaku Igaku. 1996. PMID: 8741503 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters